GGrantIndex
← Search

Leadership, Planning and Evaluation

$546,912P30FY2024CANIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications, trials & patents

Paper 39638850Paper 39604703Paper 39580301Paper 39530524Paper 39527745Paper 39516197Paper 39484544Paper 39481346Paper 39474803Paper 39462136Paper 39452931Paper 39444276Paper 39443360Paper 39432401Paper 39414902Paper 39408582Paper 39407431Paper 39402986Paper 39399121Paper 39386576Paper 39386545Paper 39379374Paper 39374311Paper 39364328Paper 39358429Paper 39345631Paper 39335130Paper 39312186Trial NCT06608511Trial NCT06557733Trial NCT05985681Trial NCT05521698Trial NCT05107219Trial NCT03725761Trial NCT03722030Trial NCT03703492Trial NCT03656276Trial NCT03393741Trial NCT03387514Trial NCT03358563Trial NCT03356470Trial NCT03342378Trial NCT03304002Trial NCT03300557Trial NCT03209869Trial NCT03185871Trial NCT03028584Trial NCT03023202Trial NCT02955043Trial NCT02917629Trial NCT02876640Trial NCT02780401Trial NCT02719821Trial NCT02169284Trial NCT02096783Trial NCT02095145Trial NCT01999881Trial NCT01935960Trial NCT01901835Trial NCT01707004Trial NCT01625156Trial NCT01325311Trial NCT01263613Trial NCT01245205Trial NCT01243359Trial NCT01233505Trial NCT01218620Trial NCT01217450Trial NCT01158274Trial NCT01083641Trial NCT01004796Trial NCT00896974Trial NCT00666562Trial NCT00544596Trial NCT00499135Trial NCT00462969Trial NCT00415025Trial NCT00410605Trial NCT00227513Trial NCT00138203Trial NCT00109863Trial NCT00079014Trial NCT00052832Trial NCT00049712Trial NCT00036790Trial NCT00028652Trial NCT00023855Trial NCT00022412Trial NCT00005794Trial NCT00004872Patent 9867974Patent 9763597Patent 9603567Patent 9470697Patent 9161720Patent 8871458Patent 6974254Patent 6438202Patent 6114119Patent 6020178

Abstract

PROJECT SUMMARY – LEADERSHIP, PLANNING AND EVALUATION Under University of Wisconsin Carbone Cancer Center (UWCCC) Director Howard Bailey, MD, a number of critical steps were taken in the planning and evaluation process during the current grant period, which includes the following: appointed additional External Advisory Board (EAB) members in informatics, COE, education, and Diversity, Equity, and Inclusion (DEI); completed 85% of prior strategic plan goals, which accelerated several initiatives in biomarkers, imaging, program grants, and a dramatic increase in philanthropy (2017: $6M; 2021: $17M); reimagined a bold future via a new strategic plan in partnership with health system leadership; conducted ad hoc reviews of COE, and emerging cores, validating three new CCSG cores (CRIC, CBC, CAMP); and facilitated bi-directional community input with a catchment expansion from 36 counties to Wisconsin’s entire 72 counties. Success in an organization provides an opportunity for leveraging achievements and forecasting a new vision. UWCCC leadership embraced assessments of emerging scientific strengths, surveillance of the oncology clinical care and research environment, and the eventual application of analysis-driven reorientation. This occurred through regular and strategic planning meetings of individual focus groups/committees of the cancer service Line; Executive Leadership Council; Senior Leadership Committee; Directors Committee; Ad Hoc Advisors; EAB; and annual scientific retreats. Our strategic planning process reorients UWCCC to leverage strengths and address challenges by expanding key new Associate Director’s roles in genomics and precision medicine, community engagement, diversity, equity, and inclusion, and a new senior medical director who will centralize the cancer service line. Dr. Bailey promoted or externally recruited new Associate Directors in faculty development and education, clinical research, and informatics. Leadership is accountable for creating an inclusive, respectful, and welcoming environment in which all members, students, and staff will thrive. All UWCCC leadership roles further the center’s mission by serving faculty members, employees, trainees, our patients, and our catchment area. Membership has grown from 198 to 218. Over 11 new initiatives directly address professional growth of trainees and staff. Two new community advocacy boards provided actionable advice, which led to a dramatic accrual rate increase for patients with race/ethnicity other than non-Hispanic White patients from 3.4% to 6.3% by 2021. We work collectively to guide planning and evaluations, create a vision, set goals, assess progress, and set the agenda for future directions. Leadership determines strategies to leverage the breadth and depth of science on the University of Wisconsin-Madison campus. Meeting monthly, they identify and foster research capabilities that will strengthen the UWCCC’s scientific programs and extend cancer focus into new areas.

View original record on NIH RePORTER →
Leadership, Planning and Evaluation · GrantIndex